Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Abilify

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Abilify was produced by Otsuka and Bristol-Myers Squibb.

NICE backs Abilify for teenagers with bipolar disorder

NICE backs Abilify for teenagers with bipolar disorder The UK's National Institute for Health and Care Excellence (NICE) has backed the use of Otsuka's Abilify in teenagers with bipolar disorder. ... This deal was recently extended following the US FDA's decision to approve of Abilify Maintena an extended

Pharma deals during March 2013

Pharma deals during March 2013 At the end of February, the FDA approved Abilify Maintena (aripiprazole), an intramuscular extended-release depot formulation for the treatment of schizophrenia and the first commercialised product to evolve from this ... injectable in 14 European

Otsuka licenses Lundbeck’s Alzheimer's drug in $825m deal

Otsuka licenses Lundbeck’s Alzheimer's drug in $825m deal Abilify Maintena (aripiprazole) in the US.

Otsuka and Lundbeck extend CNS collaboration

Otsuka and Lundbeck extend CNS collaboration Follows US approval of depot antipsychotic Abilify Maintena. Otsuka and Lundbeck have revised and extended their central nervous system (CNS) alliance in the wake of last week's approval of depot ... formulations of Abilify that are currently being

Depot Abilify approval in US buoys Lundbeck and Otsuka

Depot Abilify approval in US buoys Lundbeck and Otsuka Abilify Maintena (aripiprazole) – for which Lundbeck has partnered with Japanese pharma company Otsuka in the US - becomes the first depot formulation of a dopamine D2 partial agonist to be cleared by ... Abilify Maintena was turned down by the FDA

[ Previous 5 results ] 6 7 8 9 10 11 12 13 14 15 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health

Cello Health are expert navigators, helping healthcare clients uncover hidden insights, explore scientific options and make difficult strategic choices...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics